Question 1

What is Richard Löwenthal?

Accepted Answer

Richard Löwenthal is a Person.

Question 2

How often does Richard Löwenthal appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Richard Löwenthal first tracked by Ergen?

Accepted Answer

First tracked on Jun 26, 2026.

Question 4

When was Richard Löwenthal last mentioned in news?

Accepted Answer

Last active on Jul 01, 2026.

Question 5

What is Richard Löwenthal's current news sentiment?

Accepted Answer

Aggregate sentiment score: -60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Richard Löwenthal in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Richard Löwenthal?

Accepted Answer

ARS Pharmaceuticals Securities Investigation (Jun 26, 2026, 6 articles).

Question 8

How did the "ARS Pharmaceuticals Securities Investigation" event impact Richard Löwenthal?

Accepted Answer

Richard Löwenthal, CEO of ARS Pharmaceuticals, made several projections about Neffy's formulary coverage that are now under scrutiny as part of the securities investigation.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.